Barw Medical Journal

Lung cancer

Articles
2
Authors
21
Reads
2,360
Downloads
1,374
Citations
1

Reads are the journal’s own count. Downloads are the journal’s own count on 8 November 2026. Citations are Crossref’s count on 8 November 2026.

Adenocarcinoma Erlotinib Large cell carcinoma Microwave ablation Non-small cell lung cancer Sorafenib Squamous cell carcinoma Targeted molecular therapy Tyrosine-kinase inhibitor

Articles2

Lung cancer
  • Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review

    Fahmi H. Kakamad, Rebaz M. Ali, Soran H. Tahir, Ameer M. Salih, Berun A. Abdalla, Lana RA. Pshtiwan, Aras J. Qaradakhy, Harem K. Ahmed and 5 more

    Introduction Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it is more effective as a standalone treatment or in combination with chemotherapy warrants further investigation. This systematic review assesses the…

    2024 1,562 reads 0 citations

    doi:10.58742/bmj.v2i4.147

    Full text PDF XML

  • Efficacy of Sorafenib in the Management of Non-Small Cell Lung Cancer: A Systematic Review

    Rebaz M. Ali, Sami S. Omar, Fahmi H. Kakamad, Diyar A. Omar, Yousif M. Mahmood, Mohammed Q. Mustafa, Aland S. Abdullah, Marwan N. Hassan and 4 more

    Introduction The current standard treatment approach for non-small cell lung cancer (NSCLC) is surgery. Recently, targeted therapy has emerged as a promising new treatment option. In this systematic review, the efficacy of sorafenib, when given alone or combined with erlotinib, in managing NSCLC is reviewed. Methods…

    2024 798 reads 1 citation

    doi:10.58742/bmj.v2i2.92

    Full text PDF XML

Search within this subject